| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |